Recently, many people asked Huazi whether there is any specific medicine to treat new crown . Can the drugs recommended in the previous new crown treatment guidelines still be used now?
Huazi said that the drugs recommended in the old version of the "Diagnosis and Treatment Plan for Pneumonia Infected by New Coronavirus", such as interferon, ribavirin, chloroquine, lopinavir/ritonavir, arbidol and other drugs, have now been removed from the diagnosis and treatment plan, and the medication should be based on the current ninth edition of the plan.
1. Faced with the new virus we can only try and make mistakes in treatment
At the beginning, the new coronavirus came fiercely, and the patient's condition progressed very quickly. It was an unknown existence to humans, and everyone had no treatment experience. The whole world was "crossing the river by feeling for the stones." In the initial treatment, can only be used by selecting "possibly effective" drugs among the existing drugs.
Therefore, many drugs have been included in the diagnosis and treatment plans, so that clinicians will not be without drugs when treating patients. While is treating patients, people are also observing the efficacy of the drug. Effective ones are retained and ineffective ones are eliminated. Therefore, the diagnosis and treatment plan for the new coronavirus has been modified.
2. What are the current “specific drugs”
The new coronavirus is constantly mutating, and the corresponding diagnosis and treatment plans are constantly being modified. Currently, we are using the ninth edition of the diagnosis and treatment plan released in March 2022. Many antiviral drugs in the first eight editions were removed because there was insufficient evidence to show that these drugs were effective against the new coronavirus during their use over the past few years. In the ninth edition of the diagnosis and treatment plan,
recommended two new drugs, one is Paxlovid (nematvir/ritonavir) developed in the United States, and the other is the domestic monoclonal antibody (ambavirumab/romisevirumab injection) . These two drugs, unlike those previous "possibly effective" drugs, conducted high-quality clinical trials before being put on the market and came to effective conclusions.
There is also a third drug, Azivudine . It actually entered clinical trials in 2013 for innovative anti-HIV drugs and will be launched in 2021. However, Azivudine has broad-spectrum antiviral properties. Clinical trials against the new coronavirus began in 2020, and the trials were completed in April 2022, proving that it has anti-new coronavirus effects.
In July 2022, Azivudin received emergency approval from the State Food and Drug Administration for the treatment of new coronavirus infection. In August, it was included in the ninth edition of the diagnosis and treatment plan for the treatment of adults with new coronavirus infection.
In other words, there are currently three drugs that are effective against the new coronavirus, namely Paxlovid, Ambavir/Romisvir Injection and Azivudine . Injections are inconvenient to use, so in the eyes of ordinary people, the only "specific drugs" currently available are Paxlovid and Azivudine.
3. Rational use of COVID-19 "special effects"
I hope everyone will take a rational view of the "special effects" of COVID-19. The so-called "special effects" are just words used by the media. From a pharmaceutical point of view, can only be said to be effective therapeutic drugs for COVID-19 infection.. And even if you take medicine, you may still have fever, muscle aches, sore throat, nasal congestion, difficulty breathing, pneumonia , hypoxia, etc., and you still need to use other drugs for treatment.
There are also restrictions on the use of so-called specific drugs. is only used to treat and is not recommended for prevention; is more effective when used in the early stages of infection, , but if used after the course of the disease exceeds 5 days, it is of little significance; The use of mild patients can reduce the rate of severe illness, , but the effect is not good for severe patients.
High-risk patients such as the elderly, those with underlying diseases, those with immune deficiencies, and those who are obese will benefit more from medication., while low-risk young and middle-aged people will not benefit much from medication. The medicine itself has adverse reactions, so everyone should take medicine under the guidance of a doctor, and do not blindly follow the trend of buying medicine, let alone take medicine without permission.
To summarize, there are currently three effective anti-COVID-19 drugs, but they are not what many people call “special drugs” for COVID-19. If used unreasonably, it will not only waste money, but also bear the adverse effects of the drugs. If you have any questions about medication, please consult your doctor or pharmacist. I am Huazi, a pharmacist. Welcome to follow me and share more health knowledge. I wish everyone good health.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-